Document is current
Any future updates will be listed below
-
Authors
Nakamoto, Shogo https://orcid.org/0000-0001-8043-8608
Shien, Tadahiko https://orcid.org/0000-0003-3202-5512
Iwamoto, Takayuki https://orcid.org/0000-0001-5835-5160
Kubo, Shinichiro
Yamamoto, Mari
Yamashita, Tetsumasa
Kuwahara, Chihiro
Ikeda, Masahiko
- License Information
-
More Information
Article History
Received: 24 March 2023
Accepted: 18 April 2024
First Online: 30 April 2024
Competing interests
: Author Shogo Nakamoto has received lecture fees from Chugai Pharmaceuticals, Daiichi-Sankyo, Pfizer, and Eisai CO. Ltd. Tadahiko Shien has received lecture fees from AstraZeneca, Chugai Pharmaceuticals, Daiichi-Sankyo, Eisai, Eli-Lilly, Kyowa Kirin, Pfizer, and Nippon Kayaku. Takayuki Iwamoto has received research grant from Pfizer. Masahiko Ikeda has received lecture fees from AstraZeneca, Chugai Pharmaceuticals, Daiichi-Sankyo, Eisai, Eli-Lilly, Kyowa Kirin, Pfizer, Nippon Kayaku, and Sawai Pharmaceuticals. The other authors have no conflicts of interest to disclose.
